The Leadership Team at Cybin is responsible for setting strategic direction, guiding operational excellence, and overseeing the development and commercialization of innovative psychedelic pharmaceutical treatments. This diverse group of executives collaborates to ensure compliance with regulatory standards, drive scientific research, and foster partnerships that enhance the company's mission to improve mental health outcomes. Through their combined expertise, the team shapes Cybin's vision and growth in the biotech industry.
Aaron Bartlone
COO
Alex Nivorozhkin
Chief Scientific Officer
Amir Inamdar
Chief Medical Officer
Doug Drysdale
CEO
Eric So
President, Executive Chairman ...
Gabe Fahel
Chief Legal Officer
Greg Cavers
CFO
John Kanakis
Co-Founder
Lori Challenger
Chief Compliance, Ethics & Adm...
Paul Glavine
Co-Founder & Chief Growth Offi...
View all